IPP Bureau
AAV Production system enables scalable gene therapy workflows
By IPP Bureau - September 21, 2021
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
Glenmark receives ANDA approval for treatment of acne
By IPP Bureau - September 21, 2021
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million
By IPP Bureau - September 21, 2021
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
Lincoln Pharma plans to launch Cephalosporin product portfolio soon
By IPP Bureau - September 21, 2021
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
RxDx Healthcare receives NABL accreditation
By IPP Bureau - September 20, 2021
RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru
Qardio’s remote patient cardiac monitoring service launched
By IPP Bureau - September 20, 2021
It is the first-ever fully remote end-to-end Remote Patient Monitoring (RPM) service to include cardiac arrhythmia analysis in a single, intuitive platform
U.S. FDA concludes inspection of Lupin’s Goa facility with seven observations
By IPP Bureau - September 20, 2021
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Imfinzi plus chemotherapy tripled patient survival at 3 years
By IPP Bureau - September 20, 2021
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
Novartis’ Kisqali data indicates longest median survival in advanced breast cancer
By IPP Bureau - September 20, 2021
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
CDSCO approves Exablate 4000 for patients living with Parkinson’s disease
By IPP Bureau - September 20, 2021
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Academy of Family Physicians partner with Eka Care to build a digital platform
By IPP Bureau - September 20, 2021
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
India to resume export of Covid-19 vaccines from October
By IPP Bureau - September 20, 2021
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
By IPP Bureau - September 20, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
By IPP Bureau - September 20, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
.jpg "India extends concession on life-saving Covid-19 drugs till December 2021")
India extends concession on life-saving Covid-19 drugs till December 2021
By IPP Bureau - September 18, 2021
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
